Latest Interleukin 12 Stories
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population.
The human immune system has a natural ability to identify and attack tumor cells.
Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic study has found.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have discovered a way to amp up the power of killer T-cells, called CD8 cells, making them more functional for longer periods of time and boosting their ability to multiply and expand within the body to fight melanoma, a new study has found.
WHAT: A new study in human cells has singled out a molecule that specifically directs immune cells to develop the capability to produce an allergic response.
British scientists say they've identified the master gene that causes blood stem cells to turn into disease-fighting immune cells. Imperial College London researchers say their finding could help scientists boost the body's production of tumor-killing cells, creating new ways to treat cancer. The researchers
Canadian medical researchers say they have discovered a new anti-cancer, anti-infection response control mechanism. Dr. Andre Veillette of the Institute of Research Clinics in Montreal, and his team led by postdoctoral fellow Dr.
- totally perplexed and mixed up.